- Study type: Randomised Clinical Trial, Treatment
- Study type descriptors: Randomised controlled trial, Single centre
- Objective: To assess the safety and tolerability of an intranasal siRNA against SARS-CoV-2 (Apo-Si-K170A-C76) in healthy adults
- Number of participants enrolled: 56
- Study enrolling from to
- Study includes follow-up for 5 days
Study Data
- Adults (18-64 years)
- General population
- Elderly (≥65 years)
- Hospital
- SARS-CoV-2
- Pharmacological intervention
- Antivirals
- Apo-Si-K170A-C76
External Links
Other information
If you would like to contact the Principal Investigator of the study please email: ccb@ateneo.univr.it
The data is updated up to